The Global Market for Kidney Stone Management Devices is Projected to Reach US$1.6 Billion by 2024

Growing Volume of Kidney Stone Removal Procedures & Technology Advancements to Drive the Global Kidney Stone Management Devices Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Kidney Stone Management Devices market. The global market for Kidney Stone Management Devices is projected to reach US$1.6 billion by 2024, driven by rise in incidence of Urolithiasis, high kidney stone recurrence rate, product developments, and improving access to treatment.

Kidney Stone formation, also known as Urolithiasis is amongst the most common urological disorders worldwide, affecting two in every thousand people annually worldwide. Growth in the kidney stone management devices market is primarily driven by rise in incidence of Urolithiasis or kidney stone disease led by the surge in systemic disorders such as diabetes mellitus, and hypertension. Hence, an expanding geriatric population, and increasing obese population play a major role in driving the urinary stone management devices market. Further, increasing investments on the technology front and growing number of strategic collaborations by the players are expected to spur growth in the kidney stone management devices market.

Extracorporeal Shock Wave Lithotripsy represents the largest treatment type for Kidney Stone Management Devices market while Intracorporeal Lithotripsy constitutes the fastest growing segment.  Growth in the Intracorporeal Lithotripsy market is primarily driven by factors such as reduced cost, and early recovery in comparison to shock treatments. Tubeless Percutaneous nephrolithotomy (PCNL) is emerging as treatment of choice for management of renal and upper ureteral stones in select patients. The procedure is associated with shorter hospital stay, shorter operative time, and shorter recuperation period.

Technology advancements in the area of lithotripsy and ureteroscopy continue to redefine the kidney stone management landscape. The introduction of flexible ureteroscopes represents a major advancement in the urolithiasis treatment market given its efficacy in the treatment of intrarenal and proximal kidney stones. Growth in the modality is also supported by the improvement in image quality following the introduction of high definition cameras and digital imaging that facilitate improved visualization and more precise treatment.  The market continues to witness a notable growth in the holmium lasers for the management of kidney stones. Companies are also focusing on development of mobile and compact affordable lithotripters to widen reach to small hospitals and remote settings.

As stated by the new market research report on Kidney Stone Management Devices, the U.S. represents the largest markets worldwide. Asia-Pacific is the fastest growing market with a CAGR of 6.6% over the analysis period given the high incidence of kidney stone disease, rise in medical tourism and resultant volume of kidney stone procedures, improved healthcare spending, and increased access to advanced treatment modalities.

Major players in the market include Becton Dickinson and Company, Boston Scientific Corporation, Coloplast Group, Cook Medical, DirexGroup, Dornier MedTech, EDAP TMS SA, E.M.S. Electro Medical Systems S.A., Lumenis Ltd., New Star Lasers Inc., Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers, and Storz Medical AG, among others.

The research report titled “Kidney Stone Management Devices: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies.  The report provides market estimates and projections for all major geographic markets, such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), The Middle East & Africa, Latin America (Brazil, and Rest of Latin America).  The global market is analyzed by the following treatment types: Extracorporeal Shock Wave Lithotripsy, Percutaneous Nephrolithotomy, and Intracorporeal Lithotripsy.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.